Annovis Bio, Inc. (FRA:07X)
Germany
· Delayed Price · Currency is EUR 3.920
+0.225 (6.09%)
At close: Dec 4, 2025
Annovis Bio Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Cash & Equivalents | 15.29 | 10.55 | 5.75 | 28.38 | 45.69 | 8.07 | Upgrade
|
| Cash & Short-Term Investments | 15.29 | 10.55 | 5.75 | 28.38 | 45.69 | 8.07 | Upgrade
|
| Cash Growth | 20.97% | 83.36% | -79.72% | -37.89% | 465.79% | 434488.70% | Upgrade
|
| Prepaid Expenses | 1.9 | 0.37 | 0.04 | 0.1 | 0.07 | 0.04 | Upgrade
|
| Other Current Assets | 0.01 | 3.01 | 4.41 | 7.54 | 0.24 | 0.01 | Upgrade
|
| Total Current Assets | 17.19 | 13.93 | 10.21 | 36.02 | 46 | 8.12 | Upgrade
|
| Total Assets | 17.19 | 13.93 | 10.21 | 36.02 | 46 | 8.12 | Upgrade
|
| Accounts Payable | 2.11 | 2.31 | 1.29 | 3.96 | 0.69 | 0.34 | Upgrade
|
| Accrued Expenses | 1.62 | 1.58 | 2.99 | 3.74 | 0.82 | 0.24 | Upgrade
|
| Total Current Liabilities | 3.73 | 3.88 | 4.28 | 7.7 | 1.51 | 0.58 | Upgrade
|
| Other Long-Term Liabilities | 0.3 | 0.74 | 13.68 | - | - | - | Upgrade
|
| Total Liabilities | 4.03 | 4.62 | 17.96 | 7.7 | 1.51 | 0.58 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 167.02 | 144.16 | 102.51 | 82.38 | 73.22 | 21.78 | Upgrade
|
| Retained Earnings | -153.87 | -134.85 | -110.26 | -54.05 | -28.73 | -14.24 | Upgrade
|
| Total Common Equity | 13.16 | 9.31 | -7.75 | 28.32 | 44.49 | 7.54 | Upgrade
|
| Shareholders' Equity | 13.16 | 9.31 | -7.75 | 28.32 | 44.49 | 7.54 | Upgrade
|
| Total Liabilities & Equity | 17.19 | 13.93 | 10.21 | 36.02 | 46 | 8.12 | Upgrade
|
| Net Cash (Debt) | 15.29 | 10.55 | 5.75 | 28.38 | 45.69 | 8.07 | Upgrade
|
| Net Cash Growth | 20.97% | 83.36% | -79.72% | -37.89% | 465.79% | - | Upgrade
|
| Net Cash Per Share | 0.86 | 0.86 | 0.64 | 3.48 | 5.99 | 1.28 | Upgrade
|
| Filing Date Shares Outstanding | 26.5 | 19.49 | 11.01 | 8.22 | 8.16 | 6.95 | Upgrade
|
| Total Common Shares Outstanding | 20.19 | 14.14 | 10.52 | 8.16 | 8.1 | 6.89 | Upgrade
|
| Working Capital | 13.46 | 10.04 | 5.93 | 28.32 | 44.49 | 7.54 | Upgrade
|
| Book Value Per Share | 0.65 | 0.66 | -0.74 | 3.47 | 5.49 | 1.09 | Upgrade
|
| Tangible Book Value | 13.16 | 9.31 | -7.75 | 28.32 | 44.49 | 7.54 | Upgrade
|
| Tangible Book Value Per Share | 0.65 | 0.66 | -0.74 | 3.47 | 5.49 | 1.09 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.